An act relating to psychedelic therapy and clinical drug development trials

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors 6

Feb 3, 2026 · House

Read first time and referred to the Committee on Health Care

PASSAGE PROBABILITY

1.1% Unlikely

Why this number

Stage base Introduced — base rate 11%, measured from VT's completed sessions
Momentum -6 24/100 from the pace of recorded action
Time since last action -22 249 days quiet
Cosponsors +7 5 signed on
Bipartisan support +9 5 D · 1 I
Sponsor influence +2 65/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.